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Background
Cardiac magnetic resonance (CMR) imaging studies are
increasingly being used as surrogate endpoints in clinical
trials. There have been no previous studies investigating
what level of training is required to provide an accurate
and robust analysis of these parameters.
Methods
20 CMR studies of acute coronary syndromes were
included in this study. 6 observers with three levels of
training conducted the image analysis: Observers 1+4:
expert SCMR level 3 operators; Observers 2+5: trainees
with SCMR level 2 experience; Observers 3+6: a cardiol-
ogist and a clinical trial coordinator with no previous
CMR experience. The latter level underwent a 4hr
tutorial on how to use the software on 10 practice cases.
All 6 observers analysed 20 studies, and re-analysed 10
studies 24 hours after. Volumes and mass were analysed
using semi-automated software (Argus, Siemens), infarct
size (IS) was manually planimetered using a 2SD
threshold.
Results
Intra-observer variability was assessed using intraclass
correlation coefficient (ICC), inter-observer variability
was assessed using Bland Altman plots for agreement.
Intra-observer variability was low for volumes, and was
highest for mass measurements. (Representative results
ICC; observer 1 EDV: 0.97, ESV: 0.99, mass: 0.95, IS:
0.99 vs observer 2 EDV: 0.97, ESV: 0.98, mass: 0.91, IS:
0.98 vs observer 3 EDV: 1.0, ESV: 1.0, mass: 0.91, IS:
0.93). When compared with the most experienced
observer, inter-observer variability was highest for IS
and increased with decreasing level of experience (Table
1 for representative results for 3 of the 6 observers at 3
differing levels of experience). Bland Altman plots
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Table 1 Inter-observer variability
Observer EDV* (ml) ESV (ml) Mass (g) IS* (g)
1 vs 2 Mean (SD) difference 6.51 (8.92) 0.04 (0.13) 11.38 (15.08) -0.15 (0.49)
1 vs 2 Mean (SD) 150.59 (30.29) 4.20 (0.40) 128.48 (26.95) 2.86 (1.06)
1 vs 2 Coefficient of variation (%) 5.92 3.04 11.74 17.04
1 vs 3 Mean (SD) difference 29.70 (15.83) 0.26 (0.23) 43.47 (26.81) -0.74 (0.58)
1 vs 3 Mean (SD) 160.95 (36.28) 4.31 (0.41) 145.62 (35.55) 2.65 (1.01)
1 vs 3 Coefficient of variation (%) 9.84 5.29 18.41 21.75
Summary statistics calculated are mean and SD of differences, mean and SD of values. Differences between observers are assessed using Bland-Altman plots.
*log-transformed for skewed distribution.
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suggested acceptable agreement. Full results for all 6
observers will be presented.
Conclusions
Operator experience highly influences the accuracy of
calculating CMR parameters. When CMR LV volumes
and infarct size are used as surrogate endpoints for clin-
ical trials, a SCMR level 3 observer is the recommended
operator to perform the analysis. Based on the results of
our study, a SCMR level 2 operator will require addi-
tional experience, and a non-experienced operator sig-
nificant additional training.
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